Back to mobile site

UBS Reiterates Buy Rating on Eli Lilly (LLY)

March 24, 2025 9:00 AM EDT Send to a Friend
UBS analyst Trung Huynh reiterated a Buy rating and $1,100.00 price target on Eli Lilly (NYSE: LLY).The analyst comments "LLY ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login